{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T20:55:44Z","timestamp":1776459344713,"version":"3.51.2"},"reference-count":19,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jogoh.2017.06.006","type":"journal-article","created":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T20:16:05Z","timestamp":1498940165000},"page":"559-564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Real-world data of 197 patients treated with ulipristal acetate for uterine fibroids: PREMYA study French population main outcomes"],"prefix":"10.1016","volume":"46","author":[{"given":"H.","family":"Fernandez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Descamps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Koskas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Lop\u00e8s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Brun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Darai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Agostini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogoh.2017.06.006_bib0100","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.AOG.0000136079.62513.39","article-title":"Uterine myomas: an overview of development, clinical features, and management","volume":"104","author":"Wallach","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2017.06.006_bib0105","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.fertnstert.2007.01.093","article-title":"Etiology, symptomatology, and diagnosis of uterine myomas","volume":"87","author":"Parker","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2017.06.006_bib0110","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1472-6874-12-6","article-title":"Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women","volume":"12","author":"Zimmerman","year":"2012","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.jogoh.2017.06.006_bib0115","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejogrb.2010.05.012","article-title":"The burden of uterine fibroids in five European countries","volume":"152","author":"Downes","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jogoh.2017.06.006_bib0120","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jgyn.2014.07.006","article-title":"Pr\u00e9valence du fibrome ut\u00e9rin en France et impact sur la qualit\u00e9 de vie \u00e0 partir d\u2019une enqu\u00eate men\u00e9e aupr\u00e8s de 2500 femmes de 30\u201355 ans","volume":"43","author":"Fernandez","year":"2014","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.jogoh.2017.06.006_bib0125","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jgyn.2014.06.001","article-title":"\u00c9pid\u00e9miologie du fibrome ut\u00e9rin en France en 2010\u20132012 dans les \u00e9tablissements de sant\u00e9\u00a0\u2013\u00a0Analyse des donn\u00e9es du programme m\u00e9dicalis\u00e9 des syst\u00e8mes d\u2019information (PMSI)","volume":"43","author":"Fernandez","year":"2014","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.jogoh.2017.06.006_bib0130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0029-7844(95)00102-W","article-title":"GnRH agonist and iron versus placebo and iron in the anemic patient before surgery for leiomyomas: a randomized controlled trial","volume":"86","author":"Stovall","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2017.06.006_bib0135","first-page":"CD000547","article-title":"Preoperative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroid (review)","volume":"2","author":"Lethaby","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogoh.2017.06.006_bib0140","unstructured":"RCP (SmPC) Gonapeptyl 3,75mg (last accessed on 11 January 2017): http:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=68628809&typedoc=R."},{"key":"10.1016\/j.jogoh.2017.06.006_bib0145","unstructured":"RCP (SmPC) Decapeptyl L.P. 3mg (last accessed on 11 January 2017): http:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=67699931&typedoc=R."},{"key":"10.1016\/j.jogoh.2017.06.006_bib0150","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1479-828X.2001.tb01198.x","article-title":"An evidence-based guideline for the management of uterine fibroids","volume":"41","author":"Farquhar","year":"2001","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.jogoh.2017.06.006_bib0155","first-page":"CD008994","article-title":"Progestogens or progestogen-releasing intrauterine systems for uterine fibroids","volume":"2","author":"Sangkomkamhang","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogoh.2017.06.006_bib0160","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/PGP.0b013e318251035b","article-title":"Endometrial morphology after treatment of uterine fibroids with selective progesterone receptor modulator, ulipristal acetate","volume":"31","author":"Williams","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.jogoh.2017.06.006_bib0165","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jogoh.2017.06.006_bib0170","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jogoh.2017.06.006_bib0175","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/modpathol.2008.19","article-title":"The spectrum of endometrial pathology induced by progesterone receptor modulators","volume":"21","author":"Mutter","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jogoh.2017.06.006_bib0180","unstructured":"SmPC ESMYA (last accessed on 11 January 2017): http:\/\/www.ema.europa.eu\/docs\/fr_FR\/document_library\/EPAR_-_Product_Information\/human\/002041\/WC500124085.pdf."},{"key":"10.1016\/j.jogoh.2017.06.006_bib0185","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejogrb.2016.11.003","article-title":"Real world data of 1473 patients treated with ulipristal acetate for uterine fibroids: PREMYA study results","volume":"208","author":"Fernandez","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jogoh.2017.06.006_bib0190","article-title":"Economic impact of ulipristal acetate on surgical procedures for uterine fibroids in France","author":"Fernandez","year":"2017","journal-title":"BMJ"}],"container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784717301484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784717301484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T20:06:06Z","timestamp":1776456366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468784717301484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S2468784717301484"],"URL":"https:\/\/doi.org\/10.1016\/j.jogoh.2017.06.006","relation":{},"ISSN":["2468-7847"],"issn-type":[{"value":"2468-7847","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world data of 197 patients treated with ulipristal acetate for uterine fibroids: PREMYA study French population main outcomes","name":"articletitle","label":"Article Title"},{"value":"Journal of Gynecology Obstetrics and Human Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogoh.2017.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}